Robert Berahovich

Robert Berahovich

ProMab Biotechnologies. Inc

Affiliated withProMab Biotechnologies. IncProMab Biotechnologies

Research Area

Immunology and InfectionCancer Research

Biography

Robert Berahovich has not added Biography.
If you are Robert Berahovich and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Publication title
2019
2025

Other Publications

Article
Year
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.

Cancers| PubMed ID: 29065481

2017
2018
2019
Major Highlights of the CAR-TCR Summit, Boston, 2016.

Anti-cancer agents in medicinal chemistry| PubMed ID: 28071584

2017
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells and .

Frontiers in bioscience (Landmark edition)| PubMed ID: 28410137

2017
GITR domain inside CAR co-stimulates activity of CAR-T cells against cancer.

Frontiers in bioscience (Landmark edition)| PubMed ID: 29772559

2018
Generation of CAR-T Cells for Cancer Immunotherapy.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 30465215

2019
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells and .

Frontiers in bioscience (Landmark edition)| PubMed ID: 31585889

2020
2019
PLAP -CAR T cells mediate high specific cytotoxicity against colon cancer cells.

Frontiers in bioscience (Landmark edition)| PubMed ID: 32472757

2020
2021
2021
2023
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.

International journal of molecular sciences| PubMed ID: 37686170

2023
2024